Table 3—

OR and 95% CI for CHD, CBD, and CVD with or without coexisting metabolic syndrome in the JHS cohort aged 35–84 years

CVDCHDCBD
n422283187
Prevalence (%)12.88.75.8
OR (95% CI)1.7 (1.4–2.1)1.7 (1.3–2.2)1.7 (1.3–2.3)
Women
    Prevalence (%)11.5 (n = 235)7.3 (n = 150)5.6 (n = 110)
    OR (95% CI)1.7 (1.3–2.2)1.6 (1.1–2.2)1.9 (1.3–2.8)
Men
    Prevalence (%)16.0 (n = 187)12.0 (n = 133)6.4 (n = 77)
    OR (95% CI)1.7 (1.2–2.3)1.8 (1.3–2.7)1.5 (0.9–2.4)
  • OR is adjusted for age and sex.